Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value, Blood, vol.116, pp.2122-2126, 2010. ,
Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor, Cancer Res, vol.65, pp.8754-8765, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00187351
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis, Nucleic Acids Res, vol.41, issue.D1, pp.1034-1039, 2013. ,
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEB PA, Blood, vol.115, pp.948-956, 2010. ,
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia, Nat. Med, vol.21, pp.178-184, 2015. ,
Retinoic acid and interferon signaling cross talk in normal and RA-resistant APL cells, Leukemia, vol.13, pp.1167-1174, 1999. ,
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas, J. Natl. Cancer Inst, vol.104, pp.1458-1469, 2012. ,
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.462, pp.739-744, 2009. ,
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia, Blood, vol.121, pp.4917-4924, 2013. ,
A critical role for Lyn in acute myeloid leukemia, Blood, vol.111, pp.2269-2279, 2008. ,
Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate, Oncologist, vol.19, pp.602-607, 2014. ,
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBP?, Blood, vol.108, pp.1353-1362, 2006. ,
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, vol.18, pp.553-567, 2010. ,
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia, Cancer Cell, vol.17, pp.13-27, 2010. ,
The prognostic significance of IDH2 mutations in AML depends on the location of the mutation, Blood, vol.118, pp.409-412, 2011. ,
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2, Nat. Commun, vol.4, p.2166, 2013. ,
,
C/EBP? is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors, PLoS Genet, vol.10, p.1004079, 2014. ,
Serum 2-hydroxyglutarate production in IDH1-and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group, J. Clin. Oncol, vol.32, pp.297-305, 2014. ,
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance, Cell Stem Cell, vol.14, pp.329-341, 2014. ,
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by smallmolecule inhibition, Blood, vol.125, pp.296-303, 2015. ,
Determinants of lymphoidmyeloid lineage diversification, Annu. Rev. Immunol, vol.24, pp.705-738, 2006. ,
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible, Science, vol.339, pp.1621-1625, 2013. ,
IDH mutation impairs histone demethylation and results in a block to cell differentiation, Nature, vol.483, pp.474-478, 2012. ,
Recurring mutations found by sequencing an acute myeloid leukemia genome, N. Engl. J. Med, vol.361, pp.1058-1066, 2009. ,
Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23), Leukemia, vol.11, pp.1469-1477, 1997. ,
The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia, Front. Oncol, vol.3, p.218, 2013. ,
CCA AT/enhancer binding protein ? is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors, Mol. Cell. Biol, vol.18, pp.4301-4314, 1998. ,
Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells, Leukemia, vol.5, pp.26-31, 1991. ,
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics, Nature, vol.488, pp.656-659, 2012. ,
Reintroduction of C/EBP? in leukemic CD34 + stem/ progenitor cells impairs self-renewal and partially restores myelopoiesis, Blood, vol.110, pp.1317-1325, 2007. ,
German-Austrian AML Study Group (AML SG). 2009. Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia, Results from the AML SG Trial AML HD98B ,
, Haematologica, vol.94, pp.54-60
Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acidinduced differentiation of HL-60 human myelo-monoblastic leukemia cells, Leuk. Lymphoma, vol.52, pp.2372-2379, 2011. ,
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia, Nature, vol.506, pp.328-333, 2014. ,
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, vol.483, pp.479-483, 2012. ,
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling, Haematologica, vol.94, pp.131-134, 2009. ,
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation, Science, vol.340, pp.622-626, 2013. ,
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China, Proc. Natl. Acad. Sci. USA, vol.110, pp.17017-17022, 2013. ,